Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07700329
PHASE1
A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants
Sponsor: Celgene
View on ClinicalTrials.gov
Summary
The purpose of the study is to evaluate the drug levels, safety and tolerability of BMS-986368 in healthy Chinese participants
Official title: A Phase 1, Double-Blinded, Randomized, Placebo-Controlled, Two Parallel Cohort Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2027-01-05
Completion Date
2027-02-23
Last Updated
2026-07-14
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
BMS-986368
Specified dose on specified days
OTHER
BMS-986368-matching Placebo
Specified dose of specified days